MRK
Merck & Co., Inc. · Healthcare
EVP and CHRO Steven Mizell sold $198K of Merck & Co., Inc.
Sold$198,017
$109.10Price
1,815Shares
−5%Stake
What MRK did after the filing
- The stock from Tue, Feb 14 close, $108.74
- −3.5%
- S&P 500, same days
- −2.4%
Measured over 30 trading days, to the Mar 29 close.
Traded Mon, Feb 13. Filed Tue, Feb 14, 10:03 AM ET, during the session. Returns use the Feb 14 close and the Mar 29 close. Not investment advice.